BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9414265)

  • 1. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias.
    Schmidt M; Nagel S; Proba J; Thiede C; Ritter M; Waring JF; Rosenbauer F; Huhn D; Wittig B; Horak I; Neubauer A
    Blood; 1998 Jan; 91(1):22-9. PubMed ID: 9414265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder.
    Hao SX; Ren R
    Mol Cell Biol; 2000 Feb; 20(4):1149-61. PubMed ID: 10648600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2.
    Burchert A; Cai D; Hofbauer LC; Samuelsson MK; Slater EP; Duyster J; Ritter M; Hochhaus A; Müller R; Eilers M; Schmidt M; Neubauer A
    Blood; 2004 May; 103(9):3480-9. PubMed ID: 14656881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
    van Rhee F; Hochhaus A; Lin F; Melo JV; Goldman JM; Cross NC
    Blood; 1996 Jun; 87(12):5213-7. PubMed ID: 8652835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells.
    Tamura T; Kong HJ; Tunyaplin C; Tsujimura H; Calame K; Ozato K
    Blood; 2003 Dec; 102(13):4547-54. PubMed ID: 12933588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcr-abl regulates Stat5 through Shp2, the interferon consensus sequence binding protein (Icsbp/Irf8), growth arrest specific 2 (Gas2) and calpain.
    Hjort EE; Huang W; Hu L; Eklund EA
    Oncotarget; 2016 Nov; 7(47):77635-77650. PubMed ID: 27769062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.
    Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A
    J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas-mediated modulation of Bcr/Abl in chronic myelogenous leukemia results in differential effects on apoptosis.
    Selleri C; Maciejewski JP; Pane F; Luciano L; Raiola AM; Mostarda I; Salvatore F; Rotoli B
    Blood; 1998 Aug; 92(3):981-9. PubMed ID: 9680367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alpha.
    Schmidt M; Hochhaus A; Nitsche A; Hehlmann R; Neubauer A
    Blood; 2001 Jun; 97(11):3648-50. PubMed ID: 11369663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15(Ink4b) in murine myeloid cells.
    Schmidt M; Bies J; Tamura T; Ozato K; Wolff L
    Blood; 2004 Jun; 103(11):4142-9. PubMed ID: 14976051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages.
    Wang IM; Contursi C; Masumi A; Ma X; Trinchieri G; Ozato K
    J Immunol; 2000 Jul; 165(1):271-9. PubMed ID: 10861061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription.
    Nelson N; Marks MS; Driggers PH; Ozato K
    Mol Cell Biol; 1993 Jan; 13(1):588-99. PubMed ID: 7678054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia patient-derived lymphoblastoid cell lines exhibit increased induction of leukemia-associated transcripts following high-dose irradiation.
    Spencer A; Granter N
    Exp Hematol; 1999 Sep; 27(9):1397-401. PubMed ID: 10480430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon consensus sequence binding protein (ICSBP) decreases beta-catenin activity in myeloid cells by repressing GAS2 transcription.
    Huang W; Zhou W; Saberwal G; Konieczna I; Horvath E; Katsoulidis E; Platanias LC; Eklund EA
    Mol Cell Biol; 2010 Oct; 30(19):4575-94. PubMed ID: 20679491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
    Zhang JG; Lin F; Chase A; Goldman JM; Cross NC
    Blood; 1996 Mar; 87(6):2588-93. PubMed ID: 8630427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia.
    Deng M; Daley GQ
    Blood; 2001 Jun; 97(11):3491-7. PubMed ID: 11369642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
    Marecki S; Atchison ML; Fenton MJ
    J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.
    Tamura T; Ozato K
    J Interferon Cytokine Res; 2002 Jan; 22(1):145-52. PubMed ID: 11846985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides.
    Aichberger KJ; Mayerhofer M; Krauth MT; Skvara H; Florian S; Sonneck K; Akgul C; Derdak S; Pickl WF; Wacheck V; Selzer E; Monia BP; Moriggl R; Valent P; Sillaber C
    Blood; 2005 Apr; 105(8):3303-11. PubMed ID: 15626746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein.
    Scheller M; Foerster J; Heyworth CM; Waring JF; Löhler J; Gilmore GL; Shadduck RK; Dexter TM; Horak I
    Blood; 1999 Dec; 94(11):3764-71. PubMed ID: 10572090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.